Malignant carcinoid tumors of other sites

This code signifies the presence of a malignant neuroendocrine tumor, specifically a carcinoid, originating from an anatomical location other than the appendix, small intestine, large intestine, rectum, stomach, pancreas, or bronchus and lung. These tumors are characterized by their potential for metastasis and secretion of vasoactive substances, leading to carcinoid syndrome in some cases.

Apply this code when documentation confirms a malignant carcinoid tumor in an "other specified" primary site, such as the ovary, kidney, breast, or prostate. This diagnosis requires definitive pathology reports confirming the neuroendocrine differentiation and malignant behavior. It should be used when a more specific site-specific carcinoid code (e.g., C7A.01x, C7A.02x) is not applicable.

• Ensure the pathology report explicitly states "malignant carcinoid" and identifies a primary site not covered by more specific C7A.0x codes.
• Do not use this code for benign carcinoid tumors; refer to D3A.098 for benign counterparts of other sites.
• Sequence this code as the primary diagnosis when the malignant carcinoid is the reason for the encounter, or as a secondary diagnosis if it's a co-morbidity or being managed during an encounter for another condition.